Some lung cancer patients benefit from immunotherapy even after disease progression – Science Daily
|
Some lung cancer patients benefit from immunotherapy even after disease progression
Science Daily Some advanced lung cancer patients benefit from immunotherapy even after the disease has progressed as evaluated by standard criteria, according to research presented at the European Lung Cancer Conference (ELCC). The findings pave the way for … European Society for Medical Oncology (ESMO) – White Blood Cell … |
